All govt centres in Delhi are out of free Covid booster shots, shows CoWIN app
New Delhi/IBNS: No government health centre in the national capital has free-of-cost Covid vaccines left, while paid vaccines for all at private facilities, continue to be available over the next few days, media reports said.
The vaccines at private facilities are available at Rs. 386.25, though not in significant numbers.
The situation comes amid a massive spike in Covid cases in neighbouring China and also when the Indian government has been telling people to take the "precaution dose" or booster immediately.
At government facilities, the usual two doses are free for all, while boosters are free for those aged 60+.
On searching the official enquiry and booking portal CoWIN, there was no availability at all in North and North East Delhi, while there were some doses available at private centres in other areas of the city, said reports.
"Besides CoWIN searches, a visit to LNJP Hospital, one of Delhi's biggest government health facilities, revealed no booster availability," NDTV reported.
While the usual two-dose vaccination has been taken by over 90 per cent of the eligible population so far, only about 20 per cent of the people in Delhi — and less than 30 per cent across India — have taken the booster as cases have ebbed over the past few months.
Although Covid cases are not massively spiked in India, the Indian government has cautioned the state to be vigilant and that there is no place for complacency.
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles

Shocking: Nearly 5 million children still die before age 5 every year — Here’s why
An estimated 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to new United Nations estimates released on Tuesday – highlighting a worrying slowdown in global progress on child survival.

AstraZeneca India secures CDSCO approval for Durvalumab in advanced liver cancer
AstraZeneca Pharma India Ltd. (AZPIL) has announced that the Central Drugs Standard Control Organisation (CDSCO) has granted approval for an additional indication of Durvalumab.

Too hot to move? Study warns climate change may trigger mass inactivity and deaths
Rising global temperatures due to climate change could push millions of people into physical inactivity by 2050, potentially leading to hundreds of thousands of premature deaths and billions of dollars in lost productivity, according to a modelling study published in The Lancet Global Health.

Smoking fathers, sick kids? Study finds alarming diabetes link
A father’s nicotine exposure can affect his offspring’s ability to process sugar and may contribute to diabetes risk, according to new research using lab mice at the University of California, Santa Cruz.
Latest News

‘Wanted to establish Sharia-based Caliphate’: 19-year-old UP dental student arrested over ISIS link

I-PAC raid row: Supreme Court to resume hearing on ED’s charge against Mamata Banerjee

Shocking: Nearly 5 million children still die before age 5 every year — Here’s why

‘Caliphate in India?’ UP BDS student Harish Ali arrested for ISIS recruitment through social media

